Document:

Exhibit 10.3

 

To:  Viveon Health Acquisition Corp. LLC (the “Company”)

 

The undersigned (the “Subscriber”),
intending to be legally bound, hereby subscribes for up to $_____________ principal amount of Senior Notes due December 31, 2022, in the
form of Exhibit A hereto (the “Notes”), together with a common
stock purchase warrant to acquire one share of common stock, par value $0.001 per share (the “Common Stock”), of the
Company for each $2.00 of the funded principal amount of Notes subscribed for hereby, in the form of Exhibit
B hereto (the “Warrants”, and, together with the Notes and including the shares of Common Stock issuable
upon the exercise of the Warrants, the “Securities”). Warrants shall be issued proportionally with the drawn upon under
the Notes by the Company.

 

The Notes will provide for
a credit line to the Company up to the maximum line amount set forth therein. The Company will not have the right to reborrow any portion
of any loans made under such credit line once repaid. Together with this subscription agreement (“Subscription Agreement”).

 

If this Subscription Agreement
is accepted by the Company by the Company’s execution of this Subscription Agreement and delivery to the Subscriber of an executed
copy hereof, the Subscriber hereby commits to provide to the Company the credit line contemplated by such Subscriber’s Note. The
Subscriber understands and agrees that the Company, in its sole discretion reserves the right to accept or reject this or any other subscription
for Securities, in whole or in part. The Company shall have no obligation hereunder until the Company shall execute and deliver to the
Subscriber an executed copy of this Subscription Agreement. If this subscription is rejected, or the Offering is terminated, all funds,
if any, received from the Subscriber will be returned without interest, penalty, expense or deduction, and this Subscription Agreement
shall thereafter be of no further force or effect. If this subscription is rejected in part, the funds, if any, for the rejected portion
of this subscription will be returned without interest, penalty, expense or deduction, and this Subscription Agreement will continue in
full force and effect to the extent this subscription was accepted.

 

Subscriber shall wire the
entire amount of the subscription price (without deduction of any fees or charges), to the following account:

 

	Bank:	JPM Chase Bank, N.A.
	ABA #:	061092387
	 	 
	Account Name and Address:	
    

    Viveon Health Acquisition Corp.

    3953 Holcomb Bridge Road

    Suite 200

    Norcross GA 30092

    Attn: Rom Papadopoulos, CFO

	 	 
	Account Number:	3850372625

	 	 
	Reference:	Viveon Health Acquisition Corp. Extension Financing

 

The Subscriber hereby further
agrees, represents and warrants that:

 

(1) the Subscriber is
acquiring the Securities for the Subscriber’s own account (and not for the account of others) for investment and not with a view
to the distribution or resale thereof. Subscriber has no present intention of selling, granting any participation in, or otherwise distributing
the same. Subscriber does not have any contract, undertaking, agreement, or arrangement with any person to sell, transfer, or grant participation
to any person with respect to any of the Securities. Subscriber represents that it has full power and authority to enter into this Agreement;

 

(2) the Subscriber had a reasonable
opportunity to ask questions of and receive answers from a person or persons acting on behalf of the Company concerning the issuance
of the Securities and the business, financial condition, results of operations and prospects of the Company, and all such questions
have been answered to the full satisfaction of the undersigned. The Subscriber is satisfied that the it has received adequate
information with respect to all matters which it considers material to its decision to make this investment;

 

     

     

    

 

(3) the
Subscriber has significant prior investment experience, including investments in non-registered securities. The Subscriber is knowledgeable
about investments in special purpose acquisition companies, or SPACs. The Subscriber acknowledges that an investment in the Securities
involves substantial risks, including the loss of the full amount of the Subscriber’s investment. The Subscriber has a sufficient
net worth to sustain a loss of its entire investment in the Company in the event such a loss should occur. The Subscriber's overall commitment
to investments which are not readily marketable is not excessive in view of the Subscriber’s net worth and financial circumstances
and the purchase of the Securities will not cause such commitment to become excessive. The investment is a suitable one for the Subscriber;

 

 (4) the Subscriber is
an “accredited investor” as defined in Rule 501 of Regulation D promulgated under the Securities Act of 1933, as amended
(the “Securities Act”) as presently in effect. If other than an individual, Subscriber also represents it has not been
organized for the purpose of acquiring the Securities;

 

(5) the
Subscriber is not acquiring the Securities as a result of any form of general solicitation or general advertising as those terms are used
in Regulation D, including, without limitation, any article, notice, advertisement or other communication published in any newspaper,
magazine or similar media or broadcast over television, radio or internet or any seminar or meeting where the Subscriber was invited by
general solicitation or general advertising;

 

 (6) the Subscriber understands
that the Securities have not been registered under the Securities Act or applicable state securities laws and that the Subscriber may
not sell or otherwise dispose of the Securities, except pursuant to either an effective registration statement under the Securities Act
and in compliance with applicable state securities laws, or exemptions from the registration provisions of the Securities Act and applicable
state securities laws. The Subscriber agrees that the Subscriber will not sell or otherwise dispose of the Securities, except in compliance
with the securities laws limitations described in the foregoing sentence and understands that the Securities and such Securities will
bear legends to such effect;

 

 (7) the Subscriber will
not have any valid right, interest or claim against or upon the Company, any Subsidiary or any other Subscriber for any commission, fee
or other compensation pursuant to any agreement, arrangement or understanding entered into by or on behalf of such Subscriber;

 

(8) any
transaction documents that are being executed by the Subscriber constitute valid and legally binding obligations of the Subscriber enforceable
in accordance with their terms, except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, and other
laws of general application affecting enforcement of creditors’ rights generally and (ii) as limited by laws relating to the
availability of specific performance, injunctive relief, or other equitable remedies;

 

(9) the
Subscriber: (i) if a natural person, represents that the Subscriber has reached the age of 21 and has full power and authority to execute
and deliver this Subscription Agreement and all other related agreements or certificates and to carry out the provisions hereof and thereof;
(ii) if a corporation, partnership, or limited liability company or partnership, or association, joint stock company, trust, unincorporated
organization or other entity, such entity is duly organized, validly existing and in good standing under the laws of the state of its
organization, the consummation of the transactions contemplated hereby is authorized by, and will not result in a violation of state law
or its charter or other organizational documents, such entity has full power and authority to execute and deliver this Subscription Agreement
and all other related agreements or certificates and to carry out the provisions hereof and thereof and to purchase and hold the Securities,
the execution and delivery of this Subscription Agreement has been duly authorized by all necessary action, this Subscription Agreement
has been duly executed and delivered on behalf of such entity and is a legal, valid and binding obligation of such entity; or (iii) if
executing this Subscription Agreement in a representative or fiduciary capacity, represents that it has full power and authority to execute
and deliver this Subscription Agreement in such capacity and on behalf of the subscribing individual, ward, partnership, trust, estate,
corporation, or limited liability company or partnership, or other entity for whom the Subscriber is executing this Subscription Agreement,
and such individual, partnership, ward, trust, estate, corporation, or limited liability company or partnership, or other entity has full
right and power to perform pursuant to this Subscription Agreement and make an investment in the Company, and represents that this Subscription
Agreement constitutes a legal, valid and binding obligation of such entity. The execution and delivery of this Subscription Agreement
will not violate or be in conflict with any order, judgment, injunction, agreement or controlling document to which the Subscriber is
a party or by which it is bound;

 

    2

     

    

 

The Subscriber should check the Office of Foreign
Assets Control (“OFAC”) website at www.treas.gov/ofac before making the following representations.

 

(10) (a) the Subscriber represents
that the amounts invested by it in the Company hereby were not and are not directly or indirectly derived from activities that contravene
federal, state or international laws and regulations, including anti-money laundering laws and regulations. Federal regulations and Executive
Orders administered by OFAC prohibit, among other things, the engagement in transactions with, and the provision of services to, certain
foreign countries, territories, entities and individuals. The lists of OFAC prohibited countries, territories, persons and entities can
be found on the OFAC website at <http://www.treas.gov/ofac>. In addition, the programs administered by OFAC (the “OFAC Programs”)
prohibit dealing with individuals1 or entities in certain
countries regardless of whether such individuals or entities appear on the OFAC lists;

 

(b)  to
the best of the Subscriber’s knowledge, none of: (1) the Subscriber; (2) any person controlling or controlled by the Subscriber;
(3) if the Subscriber is a privately-held entity, any person having a beneficial interest in the Subscriber; or (4) any person for whom
the Subscriber is acting as agent or nominee in connection with this investment is a country, territory, individual or entity named on
an OFAC list, or a person or entity prohibited under the OFAC Programs. Please be advised that the Company may not accept any amounts
from a prospective investor if such prospective investor cannot make the representation set forth in the preceding paragraph. The Subscriber
agrees to promptly notify the Company should the Subscriber become aware of any change in the information set forth in these representations.
The Subscriber understands and acknowledges that, by law, the Company may be obligated to “freeze the account” of the Subscriber,
either by prohibiting additional subscriptions from the Subscriber, declining any redemption requests and/or segregating the assets in
the account in compliance with governmental regulations and the Company may also be required to report such action and to disclose the
Subscriber’s identity to OFAC. The Subscriber further acknowledges that the Company may, by written notice to the Subscriber, suspend
the redemption rights, if any, of the Subscriber if the Company reasonably deems it necessary to do so to comply with anti-money laundering
regulations applicable to the Company or any of the Company’s other service providers. These individuals include specially designated
nationals, specially designated narcotics traffickers and other parties subject to OFAC sanctions and embargo programs;

 

(c)  to
the best of the Subscriber’s knowledge, none of: (1) the Subscriber; (2) any person controlling or controlled by the Subscriber;
(3) if the Subscriber is a privately-held entity, any person having a beneficial interest in the Subscriber; or (4) any person for whom
the Subscriber is acting as agent or nominee in connection with this investment is a senior foreign political figure2,
or any immediate family3 member or close associate4
of a senior foreign political figure, as such terms are defined in the footnotes below; and

 

(d) if
the Subscriber is affiliated with a non-U.S. banking institution (a “Foreign Bank”), or if the Subscriber receives
deposits from, makes payments on behalf of, or handles other financial transactions related to a Foreign Bank, the Subscriber represents
and warrants to the Company that: (1) the Foreign Bank has a fixed address, other than solely an electronic address, in a country in which
the Foreign Bank is authorized to conduct banking activities; (2) the Foreign Bank maintains operating records related to its banking
activities; (3) the Foreign Bank is subject to inspection by the banking authority that licensed the Foreign Bank to conduct banking activities;
and (4) the Foreign Bank does not provide banking services to any other Foreign Bank that does not have a physical presence in any country
and that is not a regulated affiliate. Any notice or other communication required or permitted to be given hereunder shall be in writing
and shall be mailed by certified mail, return receipt requested, or delivered against receipt to the party to whom it is to be given (a)
if to the Company, at the address set forth above, or (b) if to the Subscriber, at the address set forth on the signature page hereof
(or, in either case, to such other address as the party shall have furnished in writing in accordance with the provisions of this Section
11). Any notice or other communication given by certified mail shall be deemed given at the time of certification thereof, except for
a notice changing a party's address which shall be deemed given at the time of receipt thereof.

 

 

		1	These individuals include specially designated nationals, specially
designated narcotics traffickers and other parties subject to OFAC sanctions and embargo programs.

 

		2	A “senior foreign political figure” is defined as
a senior official in the executive, legislative, administrative, military or judicial branches of a foreign government (whether elected
or not), a senior official of a major foreign political party, or a senior executive of a foreign government-owned corporation. In addition,
a “senior foreign political figure” includes any corporation, business or other entity that has been formed by, or for the
benefit of, a senior foreign political figure.

 

		3	“Immediate family” of a senior foreign political
figure typically includes the figure’s parents, siblings, spouse, children and in-laws.

 

		4	A “close associate” of a senior foreign political
figure is a person who is widely and publicly known to maintain an unusually close relationship with the senior foreign political figure,
and includes a person who is in a position to conduct substantial domestic and international financial transactions on behalf of the
senior foreign political figure.

 

    3

     

    

 

  (11) the
Subscriber agrees to indemnify and hold harmless the Company and its officers, directors, employees, agents, attorneys, control persons
and affiliates from and against all losses, liabilities, claims, damages, costs, fees and expenses whatsoever (including, but not limited
to, any and all expenses incurred in investigating, preparing or defending against any litigation commenced or threatened) based upon
or arising out of any actual or alleged false acknowledgment, representation or warranty, or misrepresentation or omission to state a
material fact, or breach by the Subscriber of any covenant or agreement made by the Subscriber herein or in any other document delivered
in connection with this Subscription Agreement.

 

(12) the
Subscriber hereby acknowledges and agrees that the subscription hereunder is irrevocable by the Subscriber, except as required by applicable
law, and that this Subscription Agreement shall survive the death or disability of the Subscriber and shall be binding upon and inure
to the benefit of the parties and their heirs, executors, administrators, successors, legal representatives, and permitted assigns. If
the Subscriber is more than one person, the obligations of the Subscriber hereunder shall be joint and several and the agreements, representations,
warranties, and acknowledgments herein shall be deemed to be made by and be binding upon each such person and such person's heirs, executors,
administrators, successors, legal representatives, and permitted assigns.

 

Reference is made to the final
prospectus of the Company, filed with the Securities and Exchange Commission (File Nos. 333-251112) (the “Prospectus”),
and dated as of December 28, 2020 (the “Prospectus Effective Date”). The Subscriber warrants and represents that it
has read the Prospectus and understands that Company has established a trust account containing the proceeds of its initial public offering
(the “IPO”) and from certain proceeds of a private placement occurring simultaneously with the IPO (collectively, with
interest accrued from time to time thereon, and any additional monies heretofore or hereafter added thereto, the “Trust Fund”)
for the benefit of Company’s public shareholders (the “Public Shareholders”) and certain parties (including the
underwriter and/or book-runner of the IPO) and that Company may disburse monies from the Trust Fund only: (i) to the Public Shareholders
in the event they elect to redeem the shares of Common Stock held thereby in connection with the consummation of Company’s initial
business combination (as such term is used in the Prospectus) (the “Business Combination”) or an amendment to Company’s
amended and restated certificate of incorporation, (ii) to the Public Shareholders if the Company fails to consummate a Business Combination
by March 28, 2022, unless such date has been extended by an amendment to the Company’s amended and restated certificate of incorporation,
(iii) any interest earned on the amounts held in the Trust Fund necessary to pay for income taxes or to pay dissolution expenses, or (iv)
to the Company after or concurrently with the consummation of a Business Combination. For and in consideration of Company entering into
this Subscription, the Subscriber hereby agrees that it does not now and shall not at any time hereafter have any right, title, interest
or claim of any kind in or to any monies in the Trust Fund or distributions therefrom, or make any claim against, the Trust Fund, with
respect to claims arising out of this Agreement, regardless of whether such claim arises based on contract, tort, equity or any other
theory of legal liability (any and all such claims are collectively referred to hereafter as the “Claims”). The Subscriber
hereby irrevocably waives any Claims it may have against the Trust Fund (including any distributions therefrom) now or in the future as
a result of, or arising out of, this Agreement and will not seek recourse against the Trust Fund (including any distributions therefrom)
for Claims arising out of this Agreement; provided that (x) nothing herein shall serve to limit or prohibit the Subscriber’s right
to pursue a claim against the Company for legal relief against assets held outside the Trust Fund, for specific performance or other equitable
relief, and (y) nothing herein shall serve to limit or prohibit any claims that the Subscriber may have in the future against the Company’s
assets or funds that are not held in the Trust Fund (including any funds that have been released from the Trust Fund and any assets that
have been purchased or acquired with any such funds). The Subscriber agrees and acknowledges that such irrevocable waiver is material
to this Subscription and specifically relied upon by the Company to induce it to enter in this Subscription, and the Subscriber further
intends and understands such waiver to be valid, binding and enforceable under applicable law.

 

The Company shall pay to the
Subscriber a commitment fee of 10% of all amounts funded under the Note, payable upon the funding thereof.

 

    4

     

    

 

The Company hereby agrees
that, within thirty (30) calendar days after the consummation of the Business Combination, the Company will file with the Securities and
Exchange Commission (at the Company’s sole cost and expense) a registration statement to register under and in accordance with the
provisions of the Securities Act, the resale of all Registrable Securities (as hereinafter defined) on Form S-3, Form F-3, Form S-1 or
Form F-1, as applicable. For purposes hereof, the term “Registrable Securities” means, as of any date of determination,
the securities issuable upon exercise of the Warrants (the “Warrant Shares”) and any other equity security issued or
issuable with respect thereto by way of share split, dividend, distribution, recapitalization, merger, exchange, replacement or similar
event, provided, however, that such securities shall cease to be Registrable Securities at the earliest of (A) two (2) years after the
closing date of the Business Combination, (B) the date all Securities held by Subscriber may be sold by Subscriber without volume or manner
of sale limitations pursuant to Rule 144 and without the requirement for the Company to be in compliance with the current public information
required under Rule 144(c)(1) (or Rule 144(i)(2), if applicable), (C) the date on which such securities have actually been sold by Subscriber,
or (D) when such securities shall have ceased to be outstanding.

 

Any notice or other communication
required or permitted to be given hereunder shall be in writing and shall be deemed effectively given upon personal delivery to the party
to be notified or five (5) days following deposit with the United States Post Office, by registered or certified mail, postage prepaid,
or two days after it is sent by an overnight delivery service, or when sent by facsimile with machine confirmation of delivery addressed
as follows (a) if to the Company, at the address set forth above, or (b) if to the Subscriber, at the address set forth on the signature
page hereof (or, in either case, to such other address as the party shall have furnished in writing in accordance with such provisions).

 

This Subscription Agreement
shall be governed by the laws of the State of Delaware, without regard to its conflicts of laws principles, and may be executed in one
or more counterparts, each of which shall be a binding instrument, but which together shall constitute but one agreement.

 

[REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK;

SIGNATURE PAGE FOLLOWS]

 

    5

     

    

 

In
Witness Whereof, the parties hereto have duly executed this agreement of subscription for the Securities as of the date set forth
below.

 

	Dated: March ____, 2022	 	 
	 	 	 
	 	NAME:	 
	 	 	 
	 	By:	 
	 	 	Name:	  
	 	 	Title:	 

 

	 	Address:	 
	 	Telephone No.:	 
	 	Facsimile
    No.: 	 
	 	Email Address: 	 
	 	Investment Amount: 	 

 

	Accepted and agreed:	 
	 	 	 
	VIVEON HEALTH ACQUISITION CORP.	 
	 	 	 
	By: 	 	 
	 	Name:	                           	 
	 	Title:	 	 

 

    6

     

    

 

EXHIBIT A

 

 

 

 

 

 

 

 

 

 

 

 

 

    7

     

    

 

EXHIBIT B

 

TO BE PROVIDED

 

 

 

 

 

 

 

 

 

 

8Exhibit 10.4

 

AMENDMENT TO THE

INVESTMENT MANAGEMENT TRUST AGREEMENT

 

This Amendment No. 1 (this “Amendment”),
dated as of March 23, 2022, to the Investment Management Trust Agreement (as defined below) is made by and between Viveon Health Acquisition
Corp. (the “Company”) and Continental Stock Transfer & Trust Company, as trustee (“Trustee”). All terms used
but not defined herein shall have the meanings assigned to them in the Trust Agreement.

 

WHEREAS, the Company and the Trustee entered into
an Investment Management Trust Agreement dated as of December 22, 2020 (the “Trust Agreement”);

 

WHEREAS, Section 1(i) of the Trust Agreement sets
forth the terms that govern the liquidation of the Trust Account under the circumstances described therein;

 

WHEREAS, at an annual meeting of shareholders
of the Company held on March 18, 2022, the Company shareholders approved a proposal to amend (the “Extension Amendment”) the
Company’s amended and restated certificate of incorporation (the “charter”) to (i) extend the date by which the Company
has to consummate a business combination for three months, from March 28, 2022 (the “Original Termination Date”) to June 28,
2022 (the “Extended Date”), and (ii) allow the Company, without another stockholder vote, to elect to extend the date to consummate
a business combination on a monthly basis for up to six times by an additional one month each time after the Extended Date, upon five
days’ advance notice prior to the applicable deadline, for a total of up to nine months after the Original Termination Date, unless
the closing of the proposed Business Combination with Suneva Medical, Inc. (“Suneva”) or any potential alternative initial
business combination shall have occurred (the “Additional Extension Date”); and

 

WHEREAS, prior to the date hereof, the Company
has deposited $720,000 into the trust account and filed the Extension Amendment with the Secretary of State of the State of Delaware.

 

NOW THEREFORE, IT IS AGREED:

 

		1.	Section
1(i) of the Trust Agreement is hereby amended and restated to read in full as follows:

 

“(i)
Commence liquidation of the Trust Account only after and promptly after receipt of, and only in accordance with, the terms of a letter
(“Termination Letter”), in a form substantially similar to that attached hereto as either Exhibit A or Exhibit B, signed on
behalf of the Company by its President, Chief Executive Officer or Chairman of the Board and Secretary or Assistant Secretary and, in
the case of a Termination Letter in a form substantially similar to that attached hereto as Exhibit A, acknowledged and agreed to by Chardan,
and complete the liquidation of the Trust Account and distribute the Property in the Trust Account only as directed in the Termination
Letter and the other documents referred to therein; provided, however, that in the event (i) that a Termination Letter has not been received
by the Trustee by December 28, 2022, or, (ii) prior to December 28, 2022, the Company fails to timely make the required additional monthly
deposit into the trust account to extend the date to consummate an initial Business Combination on a monthly basis, upon five days’
advance notice prior to the applicable monthly deadline, commencing with the first additional monthly deposit to be made by June 23, 2022,
and subsequent additional monthly deposits by July 23, 2022, August 23, 2022, September 23, 2022, October 23, 2022 and November 23, 2022,
the Trust Account shall be liquidated in accordance with the procedures set forth in the Termination Letter attached as Exhibit B hereto
and distributed to the Public Shareholders.”

 

     

     

    

 

		2.	Section
7(c) of the Trust Agreement is hereby amended and restated to read in full as follows:

 

“This Agreement contains the entire
agreement and understanding of the parties hereto with respect to the subject matter hereof. Except for Sections 1(i), 1(k), 1(l), 1(m),
7(c) and 7(h) (which may only be amended with the approval of the holders of at least 50% of the shares of common stock sold in the IPO,
provided that all Public Shareholders must be given the right to receive a pro-rata portion of the aggregate amount then on deposit in
the trust account (no less than $10.10 per share, plus the pro-rata additional deposits into the Trust Account, and net of taxes payable)
in connection with any such amendment), this Agreement or any provision hereof may only be changed, amended or modified by a writing signed
by each of the parties hereto; provided, however, that no such change, amendment or modification may be made without the prior written
consent of the Underwriters. As to any claim, cross-claim or counterclaim in any way relating to this Agreement, each party waives the
right to trial by jury. The Trustee may require from Company counsel an opinion as to the propriety of any proposed amendment.”

 

		3.	Section
7(j) of the Trust Agreement is hereby amended and restated to read in full as follows:

“

“(j) Each of the Company and the
Trustee hereby acknowledge that the Underwriters are a third party beneficiary of this Agreement and that each Public Shareholder is a
third party beneficiary of Sections 1(i), 1(k), 1(l), and 7(c).”

 

		4.	All other
provisions of the Trust Agreement shall remain unaffected by the terms hereof.

 

		5.	This Amendment
may be signed in any number of counterparts, each of which shall be an original and all of which shall be deemed to be one and the same
instrument, with the same effect as if the signatures thereto and hereto were upon the same instrument. A facsimile signature shall be
deemed to be an original signature for purposes of this Amendment.

 

		6.	This Amendment
is intended to be in full compliance with the requirements for an Amendment to the Trust Agreement as required by Section 7(c) of the
Trust Agreement, and every defect in fulfilling such requirements for an effective amendment to the Trust Agreement is hereby ratified,
intentionally waived and relinquished by all parties hereto.

 

		7.	This Amendment
shall be governed by and construed and enforced in accordance with the laws of the State of New York, without giving effect to conflicts
of law principles that would result in the application of the substantive laws of another jurisdiction.

 

[Signature
Page Follows]

 

    2

     

    

 

IN WITNESS WHEREOF, the parties have duly executed
this Amendment to the Investment Management Trust Agreement as of the date first written above.

 

	CONTINENTAL STOCK TRANSFER & TRUST COMPANY, AS TRUSTEE
	 
	By:	/s/ Francis Wolf	 
	Name: 	Francis Wolf	 
	Title:	Vice President	 

 

VIVEON HEALTH ACQUISITION CORP.

 

	By:	/s/ Jagi Gill	 
	Name: 	Jagi Gill	 
	Title:	Chief Executive Officer	 

 

	Acknowledged and Agreed:	 
	 	 
	Chardan Capital Markets, LLC	 
	 	 
	By: 	/s/ George Kaufman 	 
	Name:  	George Kaufman	 
	Title:		 

 

 

3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}]]